Clinical and metabolic effects of yasmin plus metformin and dianette plus metformin in women with polycystic ovary syndrome and metabolic disorders: a randomized controlled trial.

Trial Profile

Clinical and metabolic effects of yasmin plus metformin and dianette plus metformin in women with polycystic ovary syndrome and metabolic disorders: a randomized controlled trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/cyproterone (Primary) ; Metformin
  • Indications Insulin resistance; Polycystic ovary syndrome
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 21 Dec 2012 Status changed from recruiting to completed.
    • 12 Oct 2012 Results presented at the 20th FIGO World Congress of Gynecology and Obstetrics.
    • 21 May 2012 Planned end date changed from 1 Mar 2012 to 1 Sep 2011 as reported by Chinese Clinical Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top